-
Citron Research On AveXis: This Will Be One Of 2017's Biotech Blowups
Thursday, December 15, 2016 - 12:03pm | 519Citron Research's latest target is AveXis Inc (NASDAQ: AVXS), a clinical-stage gene therapy company that focuses on creating gene therapy treatments for patients suffering from neurological genetic diseases. Citron Research, the notable short-selling research firm, blasted AveXis in a report dated...